本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

2.96
-0.1500-4.82%
盤後2.990.0300+1.01%19:29 EDT
成交量:211.18萬
成交額:640.62萬
市值:3.23億
市盈率:-1.58
高:3.17
開:3.09
低:2.93
收:3.11
52周最高:6.43
52周最低:2.19
股本:1.09億
流通股本:7,878.63萬
量比:0.78
換手率:2.68%
股息:- -
股息率:- -
每股收益(TTM):-1.8756
每股收益(LYR):-2.0100
淨資產收益率:-64.41%
總資產收益率:-35.14%
市淨率:1.36
市盈率(LYR):-1.47

資料載入中...

2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

重要事件披露

Form 8-K - Current report